BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6470744)

  • 1. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats.
    Tegnèr R; Brismar T
    J Neurol Sci; 1984 Jul; 65(1):29-36. PubMed ID: 6470744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axoplasmic electrolyte contents measured by X-ray microanalysis in experimental uremic neuropathy.
    Shibahara N; Okada S; Onishi S; Hamada K; Takasaki N; Miyazaki S; Nakagaki I; Sasaki S
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):885-92. PubMed ID: 2174479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental uremic neuropathy. Part 2. Sodium permeability decrease and inactivation in potential clamped nerve fibers.
    Brismar T; Tegnèr R
    J Neurol Sci; 1984 Jul; 65(1):37-45. PubMed ID: 6088705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
    Avram MM; Feinfeld DA; Huatuco AH
    N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibratory perception threshold compared with nerve conduction velocity in the evaluation of uremic neuropathy.
    Tegnér R; Lindholm B
    Acta Neurol Scand; 1985 Apr; 71(4):284-9. PubMed ID: 4003031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high-tone external muscle stimulation on symptoms and electrophysiological parameters of uremic peripheral neuropathy.
    Strempska B; Bilinska M; Weyde W; Koszewicz M; Madziarska K; Golebiowski T; Klinger M
    Clin Nephrol; 2013 Jan; 79 Suppl 1():S24-7. PubMed ID: 23249529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.
    Goldstein DA; Chui LA; Massry SG
    J Clin Invest; 1978 Jul; 62(1):88-93. PubMed ID: 659642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibial nerve H-reflex and F-wave studies in patients with uremic neuropathy.
    Panayiotopoulos CP; Lagos G
    Muscle Nerve; 1980; 3(5):423-6. PubMed ID: 6252459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma-myoinositol concentrations in uraemic neuropathy.
    Reznek RH; Salway JG; Thomas PK
    Lancet; 1977 Mar; 1(8013):675-6. PubMed ID: 66475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Motor nerve conduction velocity in uraemic polyneuropathy: correlation with metabolic factors (author's transl)].
    Mamoli B; Kopsa H; Maly J; Pateisky K; Gerstenbrand F; Kotzaurek R
    Wien Klin Wochenschr; 1976 Dec; 88(23):770-4. PubMed ID: 1014710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats.
    Hendriksen PH; Oey PL; Wieneke GH; van Huffelen AC; Gispen WH
    J Neurol Sci; 1992 Jul; 110(1-2):99-106. PubMed ID: 1506876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. II. Is plasma myoinositol a uremic neurotoxin?
    Onishi S; Kawasaki T; Hamada K
    Bull Osaka Med Sch; 1986 Oct; 32(2):66-72. PubMed ID: 3427262
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of parathyroid hormone in the decreased motor nerve conduction velocity of chronic renal failure.
    Akmal M; Massry SG
    Proc Soc Exp Biol Med; 1990 Nov; 195(2):202-7. PubMed ID: 2236103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uremic neuropathy. Study of the motor conduction rate in patients treated with maintenance hemodialysis and peritoneal dialysis].
    Cianchetti C; Carobi C; Perticoni G; Buoncristiani U
    Riv Neurol; 1977; 47(1):83-104. PubMed ID: 193173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy.
    Ohgaki K; Nakano K; Shigeta H; Kitagawa Y; Nakamura N; Iwamoto K; Makino M; Takanashi Y; Kajiyama S; Kondo M
    Diabetes Care; 1998 Apr; 21(4):615-8. PubMed ID: 9571352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor nerve conduction velocity (MCV) and lead content in sciatic nerve of lead-exposed rats.
    Maehara N; Uchino E; Terayama K; Ohno H; Yamamura K
    Bull Environ Contam Toxicol; 1986 Jul; 37(1):47-52. PubMed ID: 3719142
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Velocity of maximal motor nerve conduction in polyneuropathies of uremic patients subjected to various types of hemodialysis for varying periods of time: values and limitations].
    Savazzi GM; Arisi L; Bignardi L; Rossi E; Cambi V; Allegri L
    Riv Neurol; 1976; 46(1):25-35. PubMed ID: 1013604
    [No Abstract]   [Full Text] [Related]  

  • 20. Maximum conduction velocity and range of conduction velocity in motor fibers of the deep peroneal nerve in patients with chronic renal insufficiency.
    van de Most van Spijk D; Dijkstra S; Jennekens FG
    Electroencephalogr Clin Neurophysiol; 1969 Sep; 27(7):715. PubMed ID: 4187432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.